Levin Capital Strategies L.P. Takes Position in Select Medical Holdings Corporation $SEM

Levin Capital Strategies L.P. bought a new stake in shares of Select Medical Holdings Corporation (NYSE:SEM) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 162,000 shares of the health services provider’s stock, valued at approximately $2,406,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Mitsubishi UFJ Trust & Banking Corp increased its holdings in Select Medical by 16.9% in the 4th quarter. Mitsubishi UFJ Trust & Banking Corp now owns 74,933 shares of the health services provider’s stock worth $1,113,000 after acquiring an additional 10,839 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH increased its holdings in Select Medical by 9.7% in the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 11,475 shares of the health services provider’s stock worth $171,000 after acquiring an additional 1,014 shares in the last quarter. First Horizon Corp purchased a new stake in Select Medical in the 4th quarter worth $52,000. State of Alaska Department of Revenue increased its holdings in Select Medical by 1.5% in the 4th quarter. State of Alaska Department of Revenue now owns 63,370 shares of the health services provider’s stock worth $940,000 after acquiring an additional 935 shares in the last quarter. Finally, Sivik Global Healthcare LLC increased its holdings in Select Medical by 8.6% in the 4th quarter. Sivik Global Healthcare LLC now owns 190,000 shares of the health services provider’s stock worth $2,822,000 after acquiring an additional 15,000 shares in the last quarter. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Trading Up 0.1%

Shares of SEM opened at $16.47 on Thursday. Select Medical Holdings Corporation has a 52-week low of $11.65 and a 52-week high of $18.53. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.89. The firm’s fifty day moving average is $16.13 and its two-hundred day moving average is $15.21. The stock has a market cap of $2.04 billion, a PE ratio of 14.32, a price-to-earnings-growth ratio of 0.94 and a beta of 1.12.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, February 19th. The health services provider reported $0.16 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.07). Select Medical had a return on equity of 7.26% and a net margin of 2.68%.The business had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.36 billion. During the same period last year, the firm earned $0.18 EPS. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Research analysts forecast that Select Medical Holdings Corporation will post 1.27 earnings per share for the current fiscal year.

Select Medical Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 12th. Shareholders of record on Monday, March 2nd were paid a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend was Monday, March 2nd. Select Medical’s payout ratio is 21.74%.

Select Medical announced that its Board of Directors has initiated a stock repurchase program on Thursday, February 19th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the health services provider to reacquire up to 49.5% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.

Analyst Ratings Changes

Several brokerages recently commented on SEM. Wall Street Zen lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, March 9th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $16.50 price target (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd. Zacks Research lowered shares of Select Medical from a “hold” rating to a “strong sell” rating in a report on Thursday, February 26th. Weiss Ratings raised shares of Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, February 20th. Finally, Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 4th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $15.63.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.